Location: Virtual | 10:00 a.m. – 11:00 a.m. ET*

Disinfection efficacy testing (DET) is a regulatory expectation for pharmaceutical, biotechnology and medical device companies to ensure a validated cleaning and disinfection process is used to maintain their aseptic processing areas.

Establishing an effective and efficient DET study is especially important in the rapidly growing Cell and Gene Therapy industry where patient safety and speed to market is crucial.

This webinar will provide guidance on how to design and conduct a scientifically sound DET study that meets regulatory expectations. Additionally, we will explore data-based case studies that highlight best practices and common challenges when conducting a DET study.

* Please note that the webinar broadcast time is listed in the Eastern Time Zone (ET). If necessary, be sure to convert to your local time zone.

Thank you for your interest, but the broadcast date for this webinar has passed. Please refer to our Events page to view upcoming events.

Meet the Presenter

Dave Shields | Senior Manager, Technical Services

Dave has over two decades of professional microbiology experience, specifically in food microbiology and aseptic manufacturing microbiology. He holds a master’s degree in management and a bachelor’s degree in biology.

For over a decade, Dave has played a key role in the development and management of STERIS’s disinfectant efficacy testing (DET) program. He has previous experience in reusable medical device cleaning and disinfection validation, biological indicator testing, microbial limits testing and antimicrobial effectiveness testing.

Dave has authored several industry publications and sits on the British Standards Institute (BSI) CH/216 Chemical Disinfectants and Antiseptics Committee, which is responsible for European disinfectant testing standards.